BackCosmo Pharmaceuticals N.V. Overview

Cosmo Pharmaceuticals N.V. Total Liabilities

Track Cosmo Pharmaceuticals N.V.'s total liabilities ($120M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$121.91M
↓ 14.96% YoYΔ $-21.45M vs prior year quarter

Peer trimmed avg / median

Loading

Cosmo Pharmaceuticals N.V. Total Liabilities History

Loading

Cosmo Pharmaceuticals N.V. vs. peers: Total Liabilities Comparison

Loading

Cosmo Pharmaceuticals N.V. Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cosmo Pharmaceuticals N.V. (CMOPF) FAQ

Cosmo Pharmaceuticals N.V. (CMOPF) currently reports a total liabilities of $120M as of June 2026. That compares with $140M in the prior-year period — down 15.0% year over year. Use the charts on this page to explore Cosmo Pharmaceuticals N.V.'s total liabilities history and peer comparisons.

Cosmo Pharmaceuticals N.V.'s total liabilities decreased from $140M to $120M — a 15.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cosmo Pharmaceuticals N.V. reported $120M in total liabilities as of June 2026. That compares with $140M in the prior-year period — down 15.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $120M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cosmo Pharmaceuticals N.V., and consider following CMOPF for alerts when major investors trade the stock.